newsfilter
← Latest News
Earnings Call Transcripts·

Clarivate Q3 Earnings Conference Call - CLARIVATE PLC

  • Explicit Guidance:

    • Full-Year 2026 Outlook:
      • Revenue: $1.965 billion to $1.985 billion (down year-over-year due to A&G books wind-down).
      • Adjusted EBITDA: $865 million to $885 million (positive growth, with all profit growth occurring in Q4).
      • Adjusted EPS: ~9% growth to $0.75 (midpoint).
      • Free Cash Flow: $320 million to $340 million.
      • Organic ACV: 1.75% to 2.25% for the full year; Q4 expected to exceed 2%.
      • Recurring Organic Revenue: 1% to 1.5% for the full year; Q4 expected to exceed 2%.
      • Organic Revenue Mix: 92% to 94%.
      • Adjusted EBITDA Margin: ~44% at midpoint; expected to maintain above 45% in Q4.
    • 2027 Outlook:
      • Free Cash Flow: Anticipated growth of 10% to 15%.
      • 2027 Full Guidance: To be provided in February 2027; target includes higher organic ACV/recurring revenue growth, increasing free cash flow, and lowered net leverage.
      • Debt Reduction: Full-year 2026 target is ~$875 million reduction in debt; Q3 saw $75 million in note repurchases at ~2% discount.
  • Business-Segment Outlook:

    • Academia & Government (AMG):
      • Growth: Sustained organic ACV and subscription growth (~2% in Q3); 95% recurring organic revenue mix.
      • New Product (Web of Science Research Intelligence): Launched May; secured 100+ institutional wins across 25 countries.
      • Pipeline: Active sales pipeline for 2026–2027 estimated at ~$20 million, expected to grow.
      • Strategy: Converting pipeline interest into recurring revenue; leveraging AI to drive retention and new sales.
    • Intellectual Property (IP):
      • Growth: Recurring organic revenue grew ~1% in Q3 (first positive growth in 3+ years); ACV returned to positive growth.
      • Revenue: $800 million franchise; 90% recurring organic revenue mix.
      • New Product (IP1): AI-native intelligence layer launching November 2026; currently working with 40+ partners (15+ Fortune Global 500).
      • Pipeline: Active sales pipeline of 151 customers, expected to increase; initial release includes 5 AI agents and 1 billion data points.
      • Expectations: IP1 expected to create new revenue streams and improve subscription retention.
    • Divestitures/Wind-downs:
      • A&G Books Business: Wind-down completed in Q2 2026; revenue impact ($48M in Q3) and profit impact ($120M full-year LSNH) excluded from continuing ops; will anniversary impact in H2 2027.
      • IP Transactional Products: Wind-down of small, low-margin products (approx. 1% of total revenue) expected to occur over the next 1–2 years.
  • Market and Competitive Outlook:

    • Demand Trends: Non-discretionary, non-deferrable work in IP segment supports resilience; A&G growth driven by modernization of national academic systems (e.g., France's national library system).
    • Pricing: Targeting pricing strength of ~3%; Q3 pricing was "consistent and strong," driving ACV growth.
    • Volume: Volume improvements noted in both segments, contributing to the return of positive ACV.
    • Competitive Positioning:
      • AMG: 99% of top 400 universities use solutions; deep integration into research/teaching workflows.
      • IP: 90% of top 100 R&D investors; used by 40+ patent/trademark offices including the five largest.
      • AI Moat: Differentiation via "agentic AI" grounded in proprietary, trusted data (465M+ AI API calls, >80 agents), inaccessible to general-purpose AI for IP1.
    • Revenue Cadence: Q4 expected to show higher total revenue due to normal patent/trademark renewal cadence and improving organic growth.
  • Macro / Industry Outlook:

    • Foreign Exchange (FX): U.S. dollar weakening against foreign currencies created a profit headwind in Q3; expected to impact full-year results but revenue impact is nominal.
    • Economic Environment: Management focuses on "non-deferrable" IP work as a hedge against discretionary spending slowdowns; sees "resilient recurring revenue stream" in academia.
    • Inflation/Costs: Cost efficiencies ($40M organic profit growth) and "disciplined cost management" cited as key margin drivers.
  • Strategic Initiatives:

    • AI Integration: Scaling "agentic AI" across platforms; IP1 to serve as an intelligence/agenting foundation; >80 in-market AI agents currently supporting customers.
    • Capital Allocation:
      • Debt Repurchase: Plan to use LSNH proceeds to repurchase 2028 and 2029 notes at a discount (targeting 2–3% discount) in Q4 2026.
      • Cash Flow Usage: Free cash flow allocated to debt reduction ($875M target full year 2026) and continued product innovation.
    • Operational Simplification: Portfolio reduced to two scaled segments (AMG, IP) following LSNH sale; elimination of low-margin transactional products.
    • Cost Reduction: Operating expenses expected to decrease by <del>$90 million for the full year; one-time transaction costs (</del>$70M) largely non-recurring in 2027.
    • CapEx: Capital spending expected to decrease by ~$35 million due to disposals and cost efficiencies, with commitment to invest in product innovation.
  • Risks and Headwinds to Outlook:

    • FX Volatility: Continued weakening of the U.S. dollar against a basket of currencies could impact profits (costs) and transaction results.
    • Wind-down Execution: Completion of IP segment low-margin product wind-downs over the next 1–2 years could impact near-term revenue mix.
    • Timing of Comparisons: A&G books business wind-down impact will anniversary in H2 2027; LSNH seasonally strong FCF not available in Q4 2026.
    • Execution Risks: Reliance on converting active sales pipelines (Web of Science, IP1) into recurring revenue at scale.
    • One-time Costs: ~$30M divestiture transaction costs and ~$70M one-time costs (non-recurring) have impacted 2026 FCF but should improve 2027 margins.
  • Management Tone on the Future:

    • Confidence Level: High confidence in the "clear path" to accelerating growth and expanding cash flow; described as a "major milestone" and "proof we delivered on commitments."
    • Strategic Shift: Transitioning from a transformation phase to an "execution" phase; focus on "sustained organic growth" and "reducing leverage."
    • Segment Sentiment: Optimistic on IP ("coming back," "very positive group") and AMG ("powerful validation" of platform scale).
    • Guidance Hedges: Explicitly narrowing guidance ranges due to three quarters of data; noting that Q4 will deliver "all" profit growth for the year.
    • Long-term View: Emphasizes that AI is "strongly positive" for the business due to the ability to apply it to trusted content and workflows.
  • Miscellaneous:

    • Financial Highlights: Q3 Continuing Operations Revenue $482M; Year-to-date $1.5B (down 5% YoY due to disposals). Q3 Adjusted Diluted EPS $0.21 (up 3 cents YoY). Adjusted EBITDA Margin expanded >300 bps in Q3.
    • KPIs: Recurring organic revenue growth 1.3% YoY in Q3; Organic ACV growth 1.8% (up 30 bps YoY).
    • Customer Validation: Mention of specific wins: France's national academic library system (Alma cloud platform) and USPTO selection for image search workflow.
    • AI Metrics: >465 million AI API calls in the platform (2.5x volume vs. prior year).
Company
CLARIVATE PLC
Keywords
CLARIVATE PLC